Amedisys, Inc. (AMED) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Net income attributable to noncontrolling interests: -66K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income attributable to noncontrolling interests: -66K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Amedisys, Inc. (NASDAQ: AMED) reported Q3 EPS of $0.33, $0.06 better than the analyst estimate of $0.27. Revenue for the quarter came in at $375.63 million versus the consensus estimate of $379.97 million.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
